Literature DB >> 29845749

Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes.

Mary J Thomson1,2, Anna S Lok1,2, Elliot B Tapper1,2,3.   

Abstract

Cirrhosis is a morbid condition associated with frequent hospitalizations and high mortality. Management of cirrhosis requires complex medication regimens to treat underlying liver disease, complications of cirrhosis and comorbid conditions. This review examines the complexities of medication management in cirrhosis, barriers to optimal medication use, and potential interventions to streamline medication regimens and avoid medication errors. A literature review was performed by searching PUBMED through December 2017 and article reference lists to identify articles relevant to medication management, complications, adherence, and interventions to improve medication use in cirrhosis. The structural barriers in cirrhosis include sheer medication complexity related to the number of medications and potential for cognitive impairment in this population, faulty medication reconciliation and limited adherence. Tested interventions have included patient self-education, provider driven patient education, intensive case management including medication blister packs and smartphone applications. Initiatives are needed to improve patient, caregiver and provider education on appropriate use of medications in patients with cirrhosis. A multidisciplinary team should be established to coordinate care with close monitoring, address patient and caregiver concerns, and to provide timely access to outpatient evaluation of urgent/complex issues. Future studies evaluating the clinical outcomes and cost effectiveness of interventions are needed.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  case management; end-stage liver disease; medication adherence; patient education

Mesh:

Year:  2018        PMID: 29845749      PMCID: PMC6202194          DOI: 10.1111/liv.13892

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  55 in total

Review 1.  Potential adverse effects of proton pump inhibitors.

Authors:  Gregory A Coté; Colin W Howden
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  A prospective study of a protocol that reduces readmission after liver transplantation.

Authors:  Mark W Russo; David M Levi; Ruth Pierce; Vincent Casingal; Lon Eskind; Andrew deLemos; Paul A Schmeltzer; Philippe J Zamor
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

Review 3.  Hepatic Encephalopathy.

Authors:  Eelco F M Wijdicks
Journal:  N Engl J Med       Date:  2016-10-27       Impact factor: 91.245

Review 4.  Hospital-based medication reconciliation practices: a systematic review.

Authors:  Stephanie K Mueller; Kelly Cunningham Sponsler; Sunil Kripalani; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2012-07-23

5.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

Review 6.  Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Sehrish Kamal; Muhammad Ali Khan; Ankur Seth; George Cholankeril; Deepansh Gupta; Utkarsh Singh; Faisal Kamal; Colin W Howden; Christopher Stave; Satheesh Nair; Sanjaya K Satapathy; Aijaz Ahmed
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

7.  Efficacy of a chronic disease management model for patients with chronic liver failure.

Authors:  Alan J Wigg; Rosemary McCormick; Rachel Wundke; Richard J Woodman
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 11.382

8.  A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis.

Authors:  Elliot B Tapper; Daniel Finkelstein; Murray A Mittleman; Gail Piatkowski; Matthew Chang; Michelle Lai
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

9.  Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy.

Authors:  Carroll B Leevy; James A Phillips
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

Review 10.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

View more
  9 in total

1.  Medication-Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention.

Authors:  Kelly L Hayward; Preya J Patel; Patricia C Valery; Leigh U Horsfall; Catherine Y Li; Penny L Wright; Caroline J Tallis; Katherine A Stuart; Katharine M Irvine; W Neil Cottrell; Jennifer H Martin; Elizabeth E Powell
Journal:  Hepatol Commun       Date:  2019-03-18

2.  Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease.

Authors:  Lubomir Skladany; Jana Vnencakova; Lukas Laffers; Beata Skvarkova; Eva Hrubá; Pavol Molcan; Tomas Koller
Journal:  Patient Prefer Adherence       Date:  2021-01-05       Impact factor: 2.711

Review 3.  How Do Patients With Cirrhosis and Their Caregivers Learn About and Manage Their Health? A Review and Qualitative Study.

Authors:  Zachary M Saleh; Patricia P Bloom; Katie Grzyb; Elliot B Tapper
Journal:  Hepatol Commun       Date:  2020-11-17

4.  Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis.

Authors:  Yue Li; Shou-Li Yuan; Jing-Ya Yin; Kun Yang; Xin-Gang Zhou; Wen Xie; Qi Wang
Journal:  World J Gastrointest Oncol       Date:  2022-07-15

5.  Medication Adherence and Compliance: Recipe for Improving Patient Outcomes.

Authors:  Taiwo Opeyemi Aremu; Oluwatosin Esther Oluwole; Kehinde Oluwatosin Adeyinka; Jon C Schommer
Journal:  Pharmacy (Basel)       Date:  2022-08-28

6.  The emotional burden of caregiving for patients with cirrhosis.

Authors:  Zachary M Saleh; Najat E Salim; Samantha Nikirk; Marina Serper; Elliot B Tapper
Journal:  Hepatol Commun       Date:  2022-07-06

7.  The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance.

Authors:  Shari S Rogal; Vera Yakovchenko; Rachel Gonzalez; Angela Park; Lauren A Beste; Karine Rozenberg-Ben-Dror; Jasmohan S Bajaj; Dawn Scott; Heather McCurdy; Emily Comstock; Michael Sidorovic; Sandra Gibson; Carolyn Lamorte; Anna Nobbe; Maggie Chartier; David Ross; Jason A Dominitz; Timothy R Morgan
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

8.  Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases.

Authors:  Carlos Lago-Hernandez; Nghia H Nguyen; Rohan Khera; Rohit Loomba; Sumeet K Asrani; Siddharth Singh
Journal:  Mayo Clin Proc       Date:  2021-06-11       Impact factor: 11.104

9.  Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis.

Authors:  Mary J Thomson; Anna S F Lok; Elliot B Tapper
Journal:  Hepatology       Date:  2021-04-19       Impact factor: 17.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.